• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性尿激酶型纤溶酶原激活物受体(suPAR)和乳酸在老年患者脓毒症诊断及死亡率预测中的作用

Role of suPAR and Lactic Acid in Diagnosing Sepsis and Predicting Mortality in Elderly Patients.

作者信息

Khater Walaa S, Salah-Eldeen Noha N, Khater Mohamed S, Saleh Asghraf N

机构信息

Medical Microbiology and Immunology Department, Faculty of Medicine, Ain Shams University , Cairo, Egypt.

Geriatrics and Gerontology Department, Faculty of Medicine, Ain Shams University , Cairo, Egypt.

出版信息

Eur J Microbiol Immunol (Bp). 2016 Jul 19;6(3):178-185. doi: 10.1556/1886.2016.00011. eCollection 2016 Sep 29.

DOI:10.1556/1886.2016.00011
PMID:27766166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5063010/
Abstract

This study investigated the diagnostic value of soluble urokinase plasminogen activator receptor (suPAR) and serum lactate in elderly patients with sepsis and evaluated their capacity to predict mortality and their correlation to Sequential Organ Failure Assessment (SOFA) score. The study included 80 participants, divided into two groups: 40 cases (mean age, 68.9 ± 5.9) admitted to the intensive care unit and 40 healthy controls (mean age, 67.1 ± 6.2). Elderly patients with sepsis had significantly higher levels of serum suPAR and lactic acid compared to healthy controls. Receiver operating characteristic (ROC) curve analysis showed that suPAR (cutoff value, ≥4.37 ng/ml) has higher area under the curve (AUC) than lactic acid (cutoff value, ≥1.95 mmol/l) for diagnosing sepsis. Serum lactate has superior prognostic value compared to suPAR with AUC of 0.82 (cutoff value, 2.2 mmol/l) and 0.72 (cutoff value, 6.3 ng/ml), respectively. The diagnostic power of combined usage of suPAR and lactate serum concentrations showed AUC of 0.988 (95% confidence interval 0.934 to 1.0). The combination of both biomarkers either together or with SOFA score may serve as a useful guide to patients who need more intensive resuscitation.

摘要

本研究调查了可溶性尿激酶型纤溶酶原激活物受体(suPAR)和血清乳酸对老年脓毒症患者的诊断价值,并评估了它们预测死亡率的能力以及与序贯器官衰竭评估(SOFA)评分的相关性。该研究纳入了80名参与者,分为两组:40例入住重症监护病房的患者(平均年龄68.9±5.9岁)和40名健康对照者(平均年龄67.1±6.2岁)。与健康对照者相比,老年脓毒症患者的血清suPAR和乳酸水平显著更高。受试者工作特征(ROC)曲线分析显示,对于脓毒症的诊断,suPAR(临界值≥4.37 ng/ml)的曲线下面积(AUC)高于乳酸(临界值≥1.95 mmol/l)。血清乳酸的预后价值优于suPAR,其AUC分别为0.82(临界值2.2 mmol/l)和0.72(临界值6.3 ng/ml)。联合使用suPAR和乳酸血清浓度的诊断效能显示AUC为0.988(95%置信区间0.934至1.0)。这两种生物标志物单独或与SOFA评分联合使用,可能为需要更强化复苏的患者提供有用的指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d9d/5063010/a9df8fe1cea0/eujmi-06-178-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d9d/5063010/11d6cf5cb5ac/eujmi-06-178-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d9d/5063010/7269ed95a4d9/eujmi-06-178-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d9d/5063010/d92ec47eee3c/eujmi-06-178-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d9d/5063010/a9df8fe1cea0/eujmi-06-178-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d9d/5063010/11d6cf5cb5ac/eujmi-06-178-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d9d/5063010/7269ed95a4d9/eujmi-06-178-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d9d/5063010/d92ec47eee3c/eujmi-06-178-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d9d/5063010/a9df8fe1cea0/eujmi-06-178-g004.jpg

相似文献

1
Role of suPAR and Lactic Acid in Diagnosing Sepsis and Predicting Mortality in Elderly Patients.可溶性尿激酶型纤溶酶原激活物受体(suPAR)和乳酸在老年患者脓毒症诊断及死亡率预测中的作用
Eur J Microbiol Immunol (Bp). 2016 Jul 19;6(3):178-185. doi: 10.1556/1886.2016.00011. eCollection 2016 Sep 29.
2
Soluble Urokinase Plasminogen Activator Receptor: A New Biomarker in the Pediatric Intensive Care Unit.可溶性尿激酶型纤溶酶原激活物受体:儿科重症监护病房中的一种新型生物标志物。
Indian J Pediatr. 2016 Jul;83(7):661-9. doi: 10.1007/s12098-016-2063-9. Epub 2016 Mar 10.
3
Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients.可溶性尿激酶型纤溶酶原激活物受体作为危重症患者的预后生物标志物
J Crit Care. 2014 Feb;29(1):144-9. doi: 10.1016/j.jcrc.2013.08.005. Epub 2013 Oct 9.
4
Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis.可溶性尿激酶型纤溶酶原激活物受体在脓毒症诊断、预后及治疗指导中的临床价值
Am J Emerg Med. 2016 Mar;34(3):375-80. doi: 10.1016/j.ajem.2015.11.004. Epub 2015 Nov 9.
5
[Prognostic power of soluble urokinase plasminogen activator receptor (suPAR) for short-term mortality in patients seen in Emergency Departments due to infections].可溶性尿激酶型纤溶酶原激活物受体(suPAR)对急诊科感染患者短期死亡率的预后价值
Rev Esp Quimioter. 2022 Feb;35(1):50-62. doi: 10.37201/req/108.2021. Epub 2021 Dec 3.
6
[Combined prognostic value of serum lactic acid, procalcitonin and severity score for short-term prognosis of septic shock patients].[血清乳酸、降钙素原及严重程度评分对脓毒症休克患者短期预后的联合预测价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Mar;33(3):281-285. doi: 10.3760/cma.j.cn121430-20201113-00715.
7
[Lactic acid, lactate clearance and procalcitonin in assessing the severity and predicting prognosis in sepsis].[乳酸、乳酸清除率及降钙素原在评估脓毒症严重程度及预测预后中的作用]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Apr;32(4):449-453. doi: 10.3760/cma.j.cn121430-20200129-00086.
8
Blood suPAR, Th1 and Th17 cell may serve as potential biomarkers for elderly sepsis management.血中可溶性尿激酶型纤溶酶原激活物受体、辅助性T细胞1(Th1)和辅助性T细胞17(Th17)可能作为老年脓毒症治疗的潜在生物标志物。
Scand J Clin Lab Invest. 2021 Oct;81(6):488-493. doi: 10.1080/00365513.2021.1952483. Epub 2021 Aug 7.
9
Serum plasminogen activator urokinase receptor predicts elevated risk of acute respiratory distress syndrome in patients with sepsis and is positively associated with disease severity, inflammation and mortality.血清纤溶酶原激活物尿激酶受体可预测脓毒症患者发生急性呼吸窘迫综合征的风险升高,且与疾病严重程度、炎症反应及死亡率呈正相关。
Exp Ther Med. 2019 Oct;18(4):2984-2992. doi: 10.3892/etm.2019.7931. Epub 2019 Aug 20.
10
[Evaluation value of human antibacterial peptide LL-37 on the prognosis of elderly patients with sepsis].[人抗菌肽LL-37对老年脓毒症患者预后的评估价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Nov;30(11):1011-1016. doi: 10.3760/cma.j.issn.2095-4352.2018.011.001.

引用本文的文献

1
The Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) as Predictive Tool in Hospitalised Patients With Community-Acquired Pneumonia (CAP).可溶性尿激酶型纤溶酶原激活物受体(suPAR)作为社区获得性肺炎(CAP)住院患者预测工具的价值
Clin Respir J. 2025 Jun;19(6):e70089. doi: 10.1111/crj.70089.
2
The Role of Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Early Indicator of Mortality in Pediatric Septic Shock.可溶性尿激酶型纤溶酶原激活物受体(suPAR)作为儿科感染性休克患者死亡率的早期指标的作用。
J Clin Lab Anal. 2024 May;38(9):e25040. doi: 10.1002/jcla.25040. Epub 2024 May 6.
3
Hierarchical Capability in Distinguishing Severities of Sepsis via Serum Lactate: A Network Meta-Analysis.

本文引用的文献

1
Sepsis: Revising definitions of sepsis.脓毒症:脓毒症定义的修订
Nat Rev Nephrol. 2015 Jun;11(6):326-8. doi: 10.1038/nrneph.2015.66. Epub 2015 Apr 28.
2
Diagnostic characteristics of a clinical screening tool in combination with measuring bedside lactate level in emergency department patients with suspected sepsis.诊断特征的临床筛选工具结合测量床边乳酸水平在急诊科病人疑似脓毒症。
Acad Emerg Med. 2014 Aug;21(8):853-7. doi: 10.1111/acem.12444. Epub 2014 Aug 24.
3
Diagnostic value of procalcitonin for bacterial infection in elderly patients - a systemic review and meta-analysis.
通过血清乳酸区分脓毒症严重程度的分层能力:一项网状Meta分析
Biomedicines. 2024 Feb 17;12(2):447. doi: 10.3390/biomedicines12020447.
4
Cytokine Storm-Definition, Causes, and Implications.细胞因子风暴-定义、原因及影响。
Int J Mol Sci. 2022 Oct 3;23(19):11740. doi: 10.3390/ijms231911740.
5
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation.可溶性尿激酶型纤溶酶原激活物受体(suPAR)作为全身性慢性炎症的生物标志物。
Front Immunol. 2021 Dec 2;12:780641. doi: 10.3389/fimmu.2021.780641. eCollection 2021.
6
Serum sTREM-1, PCT, CRP, Lac as Biomarkers for Death Risk Within 28 Days in Patients with Severe Sepsis.血清可溶性髓系细胞触发受体-1、降钙素原、C反应蛋白、乳酸作为严重脓毒症患者28天内死亡风险的生物标志物
Open Life Sci. 2018 Apr 6;13:42-47. doi: 10.1515/biol-2018-0006. eCollection 2018 Jan.
7
Host Diagnostic Biomarkers of Infection in the ICU: Where Are We and Where Are We Going?重症监护病房感染的宿主诊断生物标志物:我们现状如何,又将何去何从?
Curr Infect Dis Rep. 2021;23(4):4. doi: 10.1007/s11908-021-00747-0. Epub 2021 Feb 12.
8
An Update on Sepsis Biomarkers.脓毒症生物标志物的最新进展
Infect Chemother. 2020 Mar;52(1):1-18. doi: 10.3947/ic.2020.52.1.1.
9
Biomarkers for Point-of-Care Diagnosis of Sepsis.用于脓毒症即时诊断的生物标志物。
Micromachines (Basel). 2020 Mar 10;11(3):286. doi: 10.3390/mi11030286.
10
Prediction of mortality in adult patients with sepsis using six biomarkers: a systematic review and meta-analysis.使用六种生物标志物预测成年脓毒症患者的死亡率:一项系统评价和荟萃分析。
Ann Intensive Care. 2019 Nov 8;9(1):125. doi: 10.1186/s13613-019-0600-1.
降钙素原对老年患者细菌感染的诊断价值——系统评价和荟萃分析。
Int J Clin Pract. 2013 Dec;67(12):1350-7. doi: 10.1111/ijcp.12278.
4
Age-related differences in symptoms, diagnosis and prognosis of bacteremia.年龄相关性菌血症的症状、诊断和预后差异。
BMC Infect Dis. 2013 Jul 24;13:346. doi: 10.1186/1471-2334-13-346.
5
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.拯救脓毒症运动:严重脓毒症和脓毒性休克管理国际指南:2012 年。
Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af.
6
New approaches to sepsis: molecular diagnostics and biomarkers.新的脓毒症治疗方法:分子诊断和生物标志物。
Clin Microbiol Rev. 2012 Oct;25(4):609-34. doi: 10.1128/CMR.00016-12.
7
Soluble urokinase-type plasminogen activator receptor in patients with suspected infection in the emergency room: a prospective cohort study.急诊科疑似感染患者可溶性尿激酶型纤溶酶原激活物受体:一项前瞻性队列研究。
J Intern Med. 2012 Sep;272(3):247-56. doi: 10.1111/j.1365-2796.2012.02569.x. Epub 2012 Jul 29.
8
Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review.suPAR 作为全身炎症或感染患者的生物标志物的效用:系统评价。
Intensive Care Med. 2012 Sep;38(9):1418-28. doi: 10.1007/s00134-012-2613-1. Epub 2012 Jun 16.
9
The Prognostic Value of suPAR Compared to Other Inflammatory Markers in Patients with Severe Sepsis.与其他炎症标志物相比,可溶性尿激酶型纤溶酶原激活物受体(suPAR)在严重脓毒症患者中的预后价值
Biomark Insights. 2012;7:39-44. doi: 10.4137/BMI.S9460. Epub 2012 Apr 10.
10
suPAR as a prognostic biomarker in sepsis.可溶性尿激酶型纤溶酶原激活物受体(suPAR)作为脓毒症的预后生物标志物。
BMC Med. 2012 Jan 5;10:2. doi: 10.1186/1741-7015-10-2.